AKHIL CHANDRAKANTH KOMARAM

Mr. AKHIL CHANDRAKANTH KOMARAM

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2021 in Journal of Food Science and Technology
Verified
Journal Article
Closed access
PDF file
AKHIL CHANDRAKANTH KOMARAMAKHIL CHANDRAKANTH KOMARAM
AKHIL CHANDRAKANTH KOMARAM
EAEnti Anjaneyulu
Enti Anjaneyulu
KGKarabi Goswami
Karabi Goswami
RNRati Ranjan Nayak
Rati Ranjan Nayak
SKSanjit Kanjilal
Sanjit Kanjilal

21 September 2024 in Micromachines
Verified
Journal Article
Open access
PDF file
DBDevesh Barshilia
Devesh Barshilia
AKHIL CHANDRAKANTH KOMARAMAKHIL CHANDRAKANTH KOMARAM
AKHIL CHANDRAKANTH KOMARAM
Lai-Kwan ChauLai-Kwan Chau
Lai-Kwan Chau
Guo-En ChangGuo-En Chang
Guo-En Chang
DNA is fundamental for storing and transmitting genetic information. Analyzing DNA or RNA base sequences enables the identification of genetic disorders, monitoring gene expression, and detecting pathogens. Traditional detection techniques like polymerase chain reaction (PCR) and next-generation sequencing (NGS) have limitations, including complexity, high cost, and the need for advanced computational skills. Therefore, there is a significant demand for enzyme-free and amplification-free strategies for rapid, low-cost, and sensitive DNA detection. DNA biosensors, especially those utilizing plasmonic nanomaterials, offer a promising solution. This study introduces a novel DNA-functionalized waveguide-enhanced nanoplasmonic optofluidic biosensor using a nanogold-linked sorbent assay for enzyme-free and amplification-free DNA detection. Integrating plasmonic gold nanoparticles (AuNPs) with a glass planar waveguide (WG) and a microfluidic channel, fabricated through cost-effective, vacuum-free methods, the biosensor achieves specific detection of complementary target DNA sequences. Utilizing a sandwich architecture, AuNPs labeled with detection DNA probes enhance sensitivity by altering evanescent wave distribution and inducing plasmon resonance modes. The biosensor demonstrated exceptional performance in DNA detection, achieving a limit of detection (LOD) of 33.1 fg/mL (4.36 fM) with a rapid response time of approximately 8 min. This ultrasensitive, rapid, and cost-effective biosensor exhibits minimal background nonspecific adsorption, making it highly suitable for clinical applications and early disease diagnosis. The innovative design and fabrication processes offer significant advantages for mass production, presenting a viable tool for precise disease diagnostics and improved clinical outcomes.

24 July 2026 in Nanotechnology
Verified
Journal Article
Open access
DBDevesh Barshilia
Devesh Barshilia
AKHIL CHANDRAKANTH KOMARAMAKHIL CHANDRAKANTH KOMARAM
AKHIL CHANDRAKANTH KOMARAM
Lai-Kwan ChauLai-Kwan Chau
Lai-Kwan Chau
WHWen-Hsin Hsieh
Wen-Hsin Hsieh
Guo-En ChangGuo-En Chang
Guo-En Chang
Biosensing platforms based on localised surface plasmon resonance (LSPR) have become prominent due to their capability for label-free and real-time detection of biomolecular interactions. This paper proposes a slab waveguide-enhanced scattering-based nanoplasmonic sensing approach that utilizes the strong light–matter interaction of gold nanoparticles (AuNPs) to achieve refractive index (RI) sensing and biomolecule detection. Unlike conventional transmission or spectral-shift-based methods, the proposed system relies on monitoring variations in the scattered light intensity, providing a high-contrast and simplified detection mechanism. The sensing principle is governed by plasmonic scattering, where the intensity of scattered light increases with the surrounding RI owing to enhanced local electromagnetic field confinement. Experimental results demonstrate a clear and linear response of the normalized scattered intensity to RI variations, confirming a reliable sensing performance. A waveguide-integrated AuNP plasmonic sensor based on light scattering detection is demonstrated for RI sensing. The platform achieves high sensitivity (1.60 RIU −1 ) and resolution (6.21 × 10 −5 RIU), outperforming absorption-based detection. Enhanced evanescent coupling and LSPR significantly improve the signal response, enabling accurate, reliable, and high-resolution optical sensing in compact configurations. Furthermore, biosensing experiments using immunoglobulin G reveal a concentration-dependent signal with a limit of detection of 3.26 ng ml −1 (21.7 pM) and excellent linearity ( R 2 = 0.99), enabling accurate quantitative detection. The obtained results underscore the suitability of slab waveguide-enhanced scattering-based nanoplasmonic sensing platforms for enabling compact, cost-efficient, and high-performance solutions across biomedical diagnostics, environmental analysis, and point-of-care testing.

28 June 2026 in Micromachines
Verified
Journal Article
Open access
PDF file
AKHIL CHANDRAKANTH KOMARAMAKHIL CHANDRAKANTH KOMARAM
AKHIL CHANDRAKANTH KOMARAM
YTYen-Ta Tseng
Yen-Ta Tseng
CCChu-An Chan
Chu-An Chan
SWShau-Chun Wang
Shau-Chun Wang
CHChun-Jen Huang
Chun-Jen Huang
Lai-Kwan ChauLai-Kwan Chau
Lai-Kwan Chau
We developed a smartphone-assisted digital image-based optical biosensor array using a planar glass slide with sensor spots in a 2 × 5 array format for point-of-care multiplex detection of biomarkers. The detection is based on the integration of the capture antibody (AbC)-functionalized sensor array with a detection antibody-conjugated gold nanoparticle bioconjugate (AuNP@AbD) in the presence of interleukin-8 (IL8) to form a sandwich-type AuNP@AbD–IL8–AbC nanocomplex on the sensing spot surface. Thus, the colorimetric detection method can be applied to the quantitative analysis of IL8, a clinically relevant pro-inflammatory and pro-angiogenic biomarker. The sensing strategy utilizes digital image-based analysis via ImageJ software (V 1.54 g; Java 1.8.0_345 [64 − bit], Windows 8) to quantify the colorimetric signals generated by the light absorbance of surface-bound gold nanoparticles in response to an IL8 droplet sample of merely 8 μL on the planar glass surface, achieving a low detection limit of 0.23 pg/mL (27 fM) and good reproducibility with a coefficient of variation of 0.95%. Validation using IL8-spiked serum at concentrations of 1 × 10−9 M and 1 × 10−10 M showed minimal matrix effects with a detection accuracy of 99.5% and 106.1%, respectively. Hence, this low-cost portable digital image-based plasmonic nanoparticle-linked immunosorbent assay serves as an alternative to traditional enzyme-linked immunosorbent assays.

7 September 2015
Verified
Journal Article
Closed access
TRT Ravinder
T Ravinder
SKSwapnil Kulkarni
Swapnil Kulkarni
AKHIL CHANDRAKANTH KOMARAMAKHIL CHANDRAKANTH KOMARAM
AKHIL CHANDRAKANTH KOMARAM
BAB Anjaneyulu
B Anjaneyulu
SDSudhan Debnath
Sudhan Debnath
PCP P Chakrabarti
P P Chakrabarti